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ActivatingthePARP-1SensorComponentoftheGroucho/
TLE1 Corepressor Complex Mediates a CaMKinase
II-Dependent Neurogenic Gene Activation Pathway
entiate into neurons in response to both extrinsic and
intrinsic cues (reviewed in Bally-Cuif and Hammer-
schmidt [2003]). The commitment of neural stem cells
to the neuronal fate and their subsequent differentiation
into neurons are controlled, in part, by mechanisms in-
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volving the opposing activities of transcription factorDivision of Endocrinology
families containing the basic helix-loop-helix (bHLH) do-3Department of Cellular and Molecular Medicine
main, the Hairy/Enhancer of split (HES) family proteinsUniversity of California, San Diego
that negatively regulate neural differentiation, and otherDepartment and School of Medicine
bHLH family proteins belonging to the Neurogenin, Ash,La Jolla, California 92093
and NeuroD subgroups, collectively referred to as4Center for Cell Signaling Research
proneural proteins (reviewed in Bertrand et al. [2002];Division of Molecular Life Sciences and College
Ross et al. [2003]).of Pharmacy
The inhibitory bHLH protein, HES1, interacts withEwha Womans University
groucho (Gro)/transducin like enhancer of split (TLE)Seoul 120-750
corepressor in a manner dependent on its C-terminalKorea
WRPWmotif and serves in awell-described repressor of
MASH1 transcription preventing neuronal differentiation
(reviewed in Chen and Courey [2000]). Groucho can in-Summary
teract with HDAC1, and at least two additional compo-
nents of the Sin3 complex, Sin3 and RbAP48 (Chen et al.Switching specific patterns of gene repression and
1999; Choi et al., 1999). However, association betweenactivation in response to precise temporal/spatial sig-
TLE1 and the mammalian HDAC1-HDAC6 and the mam-nals is critical for normal development. Here we report
malian counterparts of the highly conserved RNA poly-a pathway in which induction of CaMKII triggers an
merase-associated proteins are not consistently ob-unexpected switch in the function of the HES1 tran-
served (Dasen et al., 2001), perhaps because the GPscription factor from a TLE-dependent repressor to
domain is poorly conserved in vertebrate TLEs.an activator required for neuronal differentiation.
A wide variety of enzymatic activities are critical forThese events are based on activation of the poly(ADP-
actions of these corepressors and coactivators, includ-ribose) polymerase1 (PARP-1) sensor component of
ing histone acetylation and deacetylation, phosphoryla-the groucho/TLE-corepressor complexmediating dis-
tion, ubiquitylation, and sumoylation (reviewed in Glassmissal of the corepressor complex from HES1-regu-
and Rosenfeld [2000]; McKenna and O’Malley [2002]).lated promoters. In parallel, CaMKII mediates a re-
Indeed, an ubiquitylation/proteasome pathway is widelyquired phosphorylation of HES1 to permit neurogenic
used in transcriptional regulation (Muratani and Tansey,gene activation, revealing the ability of a specific sig-
2003). In the case of liganded nuclear regulators, andnaling pathway tomodulate both the derepression and
several other classes of regulated transcription factors,the subsequent coactivator recruitment events re-
TBLR1 and TBL1 components of an N-CoR repressorquired for transcriptional activation of a neurogenic
complex serve as ligand-dependent adaptors for a re-program. The identification of PARP-1 as a regulated
quired specific ubiquitin-conjugating/19S proteasomalpromoter-specific exchange factor required for acti-
complex, with TBLR1 mediating the exchange of thevation of specific neurogenic gene programs is likely
nuclear corepressor N-CoR/SMRT for coactivators that
to be prototypic of similar molecular mechanisms.
are required for target gene activation (Perissi et al.,
2004).
Introduction An additional covalent modification recently linked to
transcription is poly(ADP-ribosyl)ation of proteins medi-
Precise spatial and temporal switches in patterns of ated by the poly(ADP-ribose) polymerase1 (PARP-1) en-
gene activation and repression are critical for proper zyme. PARP-1 catalyzes the transfer of ADP-ribose
organ development. Although a regulated exchange of chains onto glutamic acid residues of acceptor proteins,
activating and repressing DNA binding factors is one including itself (automodification), histones, transcrip-
mechanism for such events, alternative strategies can tion factors, and DNA repair proteins using NAD as a
be employed, exemplified by ligand-induced exchange substrate involved in chromatin decondensation, DNA
of corepressor for coactivator complexes in the case replication, and DNA repair. Therefore, poly(ADP-ribo-
of nuclear receptors (reviewed in Glass and Rosenfeld syl)ation by PARP-1 affects cellular processes such as
[2000]; McKenna and O’Malley [2002]). These switches apoptosis, necrosis, cellular differentiation, malignant
are of particular importance in neural development. In transformation (reviewed in D’Amours et al. [1999]), and
thedevelopingmammalian central nervous system, neu- modulations activities of transcription factors (Akiyama
ral stem cells located in the ventricular zone undergo et al., 2001; Butler andOrdahl, 1999; Hassa andHottiger,
proliferation and ultimately exit the cell cycle and differ- 2002; Plaza et al., 1999). While it has been recently re-
ported that PARP influences both the expression and
silencing at diverse times during Drosophila develop-*Correspondence: mrosenfeld@ucsd.edu
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ment (Tulin et al., 2002), it has been demonstrated that performed a biochemical purification of a TLE1 complex
using the TAP (tandem affinity purification) method, ahigh PARP enzymatic activity is observed in areas of
powerful approach used for functional proteomics stud-high transcriptional activity and chromatin decondensa-
ies in yeast and mammalian cells (Puig et al., 2001).tion on the polytene chromatin (Tulin and Spradling,
Nuclear extracts were prepared from stably transformed2003). Together these observations suggest that PARP-1
293 cells expressing TLE1 tagged with IgG binding do-may exert its function in transcription through direct
mains, TEV cleavage site, and the calmodulin bindingbinding to the gene-regulating sequences and through
peptide at its carboxyl terminus and were subjected tomodification of transcription factors by poly(ADP-ribo-
sequential purification with IgG and calmodulin affinitysyl)ation.
resins. About 13 polypeptides were found to be consis-In this manuscript, we report an unsuspected reg-
tently and specifically associated with the TAP-taggedulatory pathway required for activation of neuro-
TLE1 (compare TLE1 lane with control lane; Figure 1E).genic genes, involving both derepression and activation
MALDI-TOFmass spectrometry analyses identified nineevents based on induction of a specific calcium-depen-
of these bands as nonmuscle myosin II heavy chain,dent protein kinase, CaMKII, and derepressed genes
TopoII, Rad50, PARP-1, nucleolin, HSP70, p54nrb,regulated by the PARP-1-containing groucho/TLE1 co-
-actin, and nucleophosmin. The TLE1 complex exhib-repressor complex. PARP-1 serves as a component of
ited significant stability, even in solutions containing 300the corepressor complex, but its catalytic function
mM NaCl during purification (Figure 1F). In gel-filtrationproves to be required for subsequentMASH1 gene acti-
experiments using a Superose 6 column, most of thevation events. Induction of the CamKII-dependent sig-
polypeptides listed above migrated together with TLE1naling pathway in proliferating cortical progenitor (neu-
in fractions 14–19, except for -actin and myosin II (Fig-ral stem) cells not only causes phosphorylation of
ure 1G and data not shown). To confirm these TLE1PARP-1 and activates its enzymatic activity resulting
interactions, we performed reciprocal immunoprecipita-in dissociation of poly(ADP-ribosyl)ated components of
tion assays using 293 cells transiently expressing HA-the corepressor complex, but it also unexpectedly pro-
tagged TLE1 and individual components of TLE1 com-motes site-specific phosphorylation of HES1 required
plex (Figures 2A–2C and see Supplemental Figure S1 atfor recruitment of coactivators, providing an intriguing
http://www.cell.com/cgi/content/full/119/6/815/promoter-specific strategy for progression of neuronal
DC1/). Western blot analysis revealed that all compo-differentiation and defining a previously unknown role
nents of TLE1 complexwere coimmunoprecipitatedwithfor PARP-1 in gene regulation.
TLE1, but also with PARP-1 and nucleolin (Figures 2A–
2C). As a negative control, neither TBL1 nor -tubulinResults
showedsignificant binding affinity for the TLE1complex.
Together, these results reveal the PARP-1-containing
A TLE1-Dependent Complex Mediates
complex associated with TLE1 and show that its bio-
HES1-Dependent MASH1 Repression
chemically identified members are stably associated
in Neural Stem Cells
with TLE1 in vivo.
Cortical progenitor cells (neural stem cells [NSCs]) are All components of the TLE1 complex were expressed
maintained in a pluripotent state until signaling path- in the proliferating NSCs, as well as in brain (Figure
ways involving Ca2-dependent gene activation events 2D). ChIP analysis of theMASH1 promoter revealed the
initiate development along a neuronal pathway (Ghosh presence of all components of the TLE1 corepressor
et al., 1994; Carey and Matsumoto, 1999; Ciccolini et al., complex (Figure 2E). PARP-1 shRNA, and shRNA for2003). Thus, upon PDGF treatment nestin-expressing other individual components caused a 1.5- to 3-fold
NSCs become TuJ1 and express the proneural bHLH “derepression,” whereas unrelated, control shRNAs ex-protein, MASH1 (Figure 1A). Inspection of the promoter erted little effect on MASH1 promoter reporter activity
region of ratMASH1 revealed three class C hairy binding in 293 cells or NSCs (Figures 2G and 2H and see Supple-
sites (CACGCG) (Figure 1B), similar in sequence to that mental Figure S2B on the Cell website). Consistent with
in the Drosophila achaete gene (Van Doren et al., 1994). these findings, we could detect little derepression of
To investigate the process by which the Notch/Delta- endogenous MASH1 expression in proliferating NSCs
induced bHLH repressor of HES1 blocks expression of microinjectedwith shRNAagainst TLE1and components
MASH1 in proliferating NSCs, we used chromatin immu- of the TLE1 complex (data not shown). Taken together,
noprecipitation (ChIP) assays, finding that both HES1 these data indicate that the TLE1 holocomplex is re-
and TLE1 were present on the MASH1 promoter in rat quired for HES1-mediated repression, but that individual
NSCs (Figure 1B). A role for TLE1 inmediating repression components of the TLE1 complex exert quantitatively
of the MASH1 promoter was validated by identifying smaller effects on repression of MASH1 transcription.
a plasmid-based RNA-mediated interference (shRNA) To evaluate whether the enzymatic activity of PARP-1
against TLE1 that caused significant inhibition of HES1- plays a role in the HES1-mediated MASH1 repression,
dependent repression of MASH1, contingent upon the we used the PARP-1 enzyme inhibitor, 3AB (3 amino-
presence of the three HES1 binding sites (Figures 1C benzamide). Interestingly, no significant change in re-
and 1D). No similar repression was observed when the pression of MASH1 in 293 cells was observed (Figure
MASH1promoter harboringmutations (Chenet al., 1997) 2I), suggesting that PARP-1 enzymatic activity is not
in each of the three HES1 binding sites was used in required for repression. Addition of 3AB (100M) did not
similar transfection experiments (Figure 1D). itself induce MASH1 transcription in FGF2-maintained
In order to better understand the molecular mecha- NSC cultures (See Supplemental Figure S3 online), fur-
nisms of TLE1-dependent neurogenic gene repression ther showing that the enzymatic activity of PARP-1 is
not required for active repression by the TLE1 complex.and derepression events upon NSC differentiation, we
CaMKII/PARP-1-Mediated Derepression in Neurogenesis
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Figure 1. HES1/TLE1-Dependent Repression of MASH1 in Neural Stem Cells (NSCs) and Identification of TLE1 Complex
(A) Expression of Nestin and Tuj1, in rat NSC cultures treated with PDGF and induced expression of MASH1.
(B) Recruitment of HES1 and TLE1 in the HES1 binding sites of the MASH1 promoter (1,2,3), required for repression, as analyzed by ChIP. II
represents PCR amplification using primers that cover the coding region of the MASH1 gene.
(C and D) TLE1 shRNA inhibits HES1-dependent repression ofMASH1 promoter-driven reporter activity in 293 cells and NSCs.MASH1 promoter
mutated in (1,2,3) HES1 binding sites fail to exhibit HES1-dependent repression.
(E) Purification of TLE1 complex and mass spectrometric analysis of polypeptides associated with TLE1. For control experiment, empty vector
(pCDNA3-TAP) were stably transfected into 293 cells. The identities of TLE1-associated polypeptides are indicated at the right. Degraded
forms of nonmuscle myosin II (*) and TLE1 (**) were identified by Western blot analysis.
(F) The TLE1 complex was purified in the presence of 150 or 300 mM NaCl using TAP method.
(G) Gel filtration analysis of the purified TLE1 complex. The numbers over the lanes represent the eluted fraction number.
Regulated Dismissal of TLE1 Corepressor of MASH1 activation are reported to occur after 24 hr
of PDGF treatment (Enarsson et al., 2002 and data notComplex and MASH1 Activation
To investigate how the TLE1 complex is dismissed and shown). As expected, PDGF treatment caused dismissal
of TLE1 and many components of the TLE1 complex,what events are required for MASH1 gene activation,
we analyzed MASH1 promoter occupancy by various but not HES1, PARP-1, and p54nrb (Figure 3A), consis-
tent with activation of MASH1 gene expression. Thecofactors by performing ChIP assays in differentiating
rat NSCs treated with PDGF for 24 hr. Maximum levels MASH1 promoter is now occupied by HAT-containing
Cell
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Figure 2. TLE1 Complex Represses MASH1
in Proliferating Neural Stem Cells
(A–C) Reciprocal immunoprecipitation assay.
HA-tagged (HA-) TLE1 (A), HA-PARP-1 (B),
and HA-nucleolin (C) were transfected into
293 cells.
(D) Expression of TLE family and TLE1-asso-
ciated proteins were analyzed by RT-PCR
assay in the proliferating NSCs and adult
mouse brain.
(E) ChIP analysis on rat MASH1 promoter by
components of the TLE1 complex in the pro-
liferating rat NSCs treated with FGF2.
(F) PARP-1 is efficiently knocked down by
PARP-1 shRNA.
(G and H) Effects of PARP-1 shRNA on co-
transfected MASH1 promoter reporter activ-
ity in 293 cells (G) and NSCs treated with
FGF2 (H).
(I) PARP-1 is associated with the TLE1 com-
plex in an enzymatically inactive form. Trans-
fected cells were treated with the inhibitors
for PARP-1 (3AB) for 12 hr.
coactivator complexes, including CBP, p/CAF, the p160 and H4 were present on the MASH1 promoter following
the replacement of the corepressor complexes by HAT-factor Src1, and acetylated H3/H4 histones and PolII
(Figure 3A). containing coactivator complexes (Figure 3B). Unex-
pectedly, we continued to detect the presence of HES1Components of the TLE1 complex remained associ-
atedwith theMASH1promoter for 6–9 hr followingPDGF and PARP-1, as well as p54nrb, on theMASH1 promoter
throughout repression and activation events, raising in-treatment and were then dismissed, consistent with the
time lag (8–10 hr) required to induce MASH1 gene ex- triguing questions concerning their potential roles in
MASH1 gene activation events.pression (Figure 3B) and the 9–10 hr to observe en-
hanced levels of MASH1 mRNA in response to PDGF
treatment (data not shown). This result suggests that Induction of CaMKII Is Linked to MASH1
Derepression EventsPDGF-dependent event(s) must be required for MASH1
activation in the differentiating NSCs (vide infra). By 12 Because previous studies indicate that several protein
kinase pathways are involved in neuronal differentiationhr following PDGF treatment, the CBP-containing co-
activator complexes, Pol II, and acetylated histones H3 (Stro¨m et al., 1997; Enarsson et al., 2002; Me´nard et al.,
CaMKII/PARP-1-Mediated Derepression in Neurogenesis
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Figure 3. Dismissal of TLE1 Corepressor Complex and HES1-Dependent Recruitment of PARP-1-Containing Coactivator Complex
(A) ChIP analysis on MASH1 promoter in differentiating rat NSCs.
(B) Time curve of PDGF-induced switch in occupancy of MASH1 promoter, first by the TLE1 corepressor complex and later by coactivator
complexes after PDGF treatment.
(C) Effects of CaMK inhibitor on MASH1 expression.
(D) MASH1 activation associated with CaMKII. The time curve of occupancy of CaMKII on MASH1 promoter was analyzed by ChIP.
(E) Effects of KN-62 on PDGF-dependent factor/cofactor recruitment to the MASH1 promoter in rat NSCs.
(F) CaMKII activity is required for MASH1 activation. After microinjection of KN-62 with TRITC-conjugated dextran together, the NSCs were
maintained in the PDGF containing media for 48 hr. Photomicrographs of MASH1 expression in the KN-62-injected NSC are shown on the
right, while fold increase of MASH1 expression is shown on the left as assessed by the NIH Image Program.
(G) The time induction curve of CaMKII, , , and  by RT-PCR of differentiating NSCs.
(H) CaMKII shRNA selectively inhibits MASH1 expression. The cells were immunostained with MASH IgG.
2002; Vojtek et al., 2003), we investigated the hypothesis inhibitor of calcium/calmodulin-dependent protein ki-
nase (CaMK), KN-62 (5 M), significantly blocked PDGF-that specific protein kinases functionally modify, or in-
teract with, HES1 and/or cofactors on the MASH1 pro- inducedneuronal differentiation asdeterminedbyevalu-
ating the expression of MASH1 transcripts (Figure 3C).moter in differentiating NSCs. Initially using inhibitors
of specific protein kinases, we showed that a specific ChIP analysis revealed that CaMKII was recruited to the
Cell
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MASH1 promoter upon PDGF treatment in contrast to induction of CaMKII dictates the temporal aspects of
MASH1 activation.other tested protein kinases including CaMKIV, PKC,
and RSKs (Figure 3D). Although PKC signaling is impor-
tant for NGF-induced neuronal differentiation in the Poly(ADP-ribosyl)ation Activity of PARP-1 Is
PC12 pheochromocytoma cell line (Stro¨m et al., 1997), Required for Dismissal of the TLE1 Corepressor
PKC inhibitors exerted minimal effects on MASH1 ex- Complex in Neural Stem Cell Differentiation
pression in the differentiating NSCs (data not shown). The PARP-1 component of the TLE1 transcriptional co-
Analysis of the time course of CaMKII recruitment repressor complex in proliferating NSCs (Figure 2E) re-
showed that it was initially detected on theMASH1 pro- mains bound to theMASH1 promoter in NSCs differenti-
moter 7–9 hr following addition of PDGF and remained ating into neurons (Figures 3A and 3B). While PARP-1
even after recruitment of the coactivator complexes plays a critical role in chromatin structure during DNA
(Figure 3D). Together, these data suggest that activation repair, its role in chromatin remodeling and transcrip-
of some members of the CaMKII family represents a tional regulation has been recently reported (reviewed
prerequisite for PDGF-induced MASH1 activation and in Kraus and Lis [2003]; Rouleau et al. [2004]). To investi-
NSC differentiation. Addition of KN-62 in PDGF-treated gate potential functions of PARP-1 in derepression
cells blocked release of the TLE1/PARP-1 corepressor events, the poly(ADP-ribosyl)ation activity of PARP-1
complex from the MASH1 promoter, as detected by wasassessedbyWestern blot analysis (Figure 4A). Poly-
ChIP (Figure 3E). To functionally test this model, we (ADP-ribosyl)ated PARP-1 was detected using anti-
investigated the effects of inhibiting CaMKII by KN-62 poly(ADP-ribose) antibody (PAR) from nuclear extract
onMASH1 gene activation in differentiating NSCs using of PDGF-treated NSCs. A significantly higher level of
the single-cell nuclear microinjection assay. MASH1 ex- poly(ADP-ribosyl)ation of PARP-1 was observed follow-
pression was inhibited by microinjection of KN-62 in a ing PDGF treatment of NSCs for 12 hr, after which, poly
dose-dependent manner (Figure 3F), consistent with a (ADP-ribosyl)ation of PARP-1 actually declined (Figure
functional role of recruitment of isoform(s) of CaMKII. 4A and data not shown). In T3-1 cells treated with KCl
CaMKII isoforms termed , , , and  constitute a to cause Ca2 signaling, most components of the TLE1
family of multifunctional protein kinases that play a ma- complex, except p54nrb, could be poly(ADP-ribo-
jor role in Ca2-mediated signal transduction (reviewed syl)ated (See Supplemental Figures S5A and S5B), con-
in Hudmon and Schulman [2002]). A dramatic increase sistent with the recent report that calcium signaling
in  isoforms mRNA level was observed at a time that can regulate poly(ADP-ribosyl)ation activity of PARP-1
correlates with the start of dendritic maturation and in- (Homburg et al., 2000; Kun et al., 2004). To ascertain if
creased synapse formation (Sugiura and Yamauchi, similar events occurred in neural stem cells, we treated
1992; Bayer et al., 1999). Remarkably, only - and -CaM NSCs with PDGF and evaluated poly(ADP-ribosyl)ation
kinase II are expressed during early embryonic brain of TLE1, TopoII, Rad50, nucleolin, and nucleophosmin
development and they might be involved in the early finding that each exhibited PDGF-dependent poly(ADP-
events of neurogenesis (Bayer et al., 1999). The isoforms ribosyl)ation (Figure 4B). Because it has been shown
of CaMKII are also the principal CaMK gene products that addition of an anionic polymer on a protein can
expressed during adipocyte and cardiac differentiation prevent interaction with other anionic molecules (re-
(Wang et al., 1997; Hoch et al., 1998). However, specific viewed in D’Amours et al. [1999]; Ferro and Olivera
functions of CaMKII and  remain unknown. The NSCs [1982]), we suggest that poly(ADP-ribosyl)ation of many
exhibited no detectable expression of any CaMKII iso- components of the TLE1 complex is a key event in com-
form, but levels of CaMKII transcripts were markedly plex dismissal.
induced after 7–9 hr of PDGF treatment (Figure 3G), To independently test the hypothesis that calcium
consistent with the time course of MASH1 gene activa- signaling-dependent poly(ADP-ribosyl)ation is coupled
tion. CaMKII exhibited similar kinetics of induction, but to dismissal of the TLE1 complex, Ca2 was added
at levels 20-fold lower, and the protein was not de- to nuclear extracts from HA/TLE1-overexpressing 293
tected on Western blot analysis (Figure 3G and data cells (CamKII) during immunoprecipitation procedures.
not shown). These results suggested that induction of Dissociation of the TLE1 complex was observed in a
CaMKII is likely to provide the molecular explanation Ca2 concentration-dependent manner (Figure 4C). In-
for the temporal “lag” in the switch from HES1/TLE1- terestingly, most of the components we have identified
dependent repression to activation ofMASH1. We devel- in the TLE1-associated corepressor complex have been
oped a CaMKII shRNA in a modified pSuper vector ex- reported to be regulated by Ca2 (Ackerman et al., 1988;
pressing EGFP that markedly reduced levels of CaMKII Gilchrist et al., 2002; Herrera et al., 1995; Kun et al.,
protein in Western blot analysis (See Supplemental Fig- 2004). To confirm these data, we performed immunopre-
ure S4 online), transfected this versus control shRNA cipitation experiments using T3-1 cells, which already
into rat NSCs, and evaluated expression of MASH1 48 express CaMKII, transfected with HA-TLE1/Flag-HES1
hr after PDGF treatment. As seen in Figure 3H, there was expression vectors. The cells were cultured in the pres-
an effective block of MASH1 expression with CaMKII ence or absence of KCl (50 mM) for 12 hr. In accordance
shRNA but not with control shRNA, indicating that induc- with the in vitro assays, KCl-evoked calcium signaling
tion of CaMKII was specifically required for dismissal caused a dissociation of the TLE1 complex in vivo, even
of the TLE1 corepressor complex and activation of after KCl treatment for 10 min (Figure 4D and data not
MASH1. Together, these data suggest that the activity shown). These data also suggest that the “lag” in disso-
of CaMKII is required for PDGF-inducedMASH1 activa- ciation of TLE1 complex that occurs in NSCs only after
CaMKII induction does not occur in cells already ex-tion in differentiating rat NSCs and that the kinetics of
CaMKII/PARP-1-Mediated Derepression in Neurogenesis
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Figure 4. Activation of Poly(ADP-ribosyl)a-
tion Function of PARP-1 Is Required for
MASH1 Activation during Neural Stem Cell
Differentiation
(A) PDGF treatment induces poly(ADP-ribo-
syl)ation of PARP-1 in the differentiating rat
NSCs.
(B) Components of the TLE1 complex can be
poly(ADP-ribosyl)ated by PDGF treatment.
(C) Calcium induces TLE1 complex dissocia-
tion. Nuclear extracts from HA/TLE1 overex-
pressed 293 cells were incubated at 37C for
5 min in the presence of CaCl2. Purification
of the TLE1 complex using HA IgG and
Western blot analysis was performed.
(D) KCl-evoked calcium signaling induces
TLE1 complex dissociation in vivo. Incu-
bation overexpressing HA-TLE1/Flag-HES1
T3-1 cells with 50 mM KCl  1 mM 3AB
for 12 hr and purification of the TLE1/HES1
complex using HA IgG and Western blot
analysis were performed.
(E) ChIP analysis of the MASH1 promoter in
NSCs treated with PDGF  3AB, showing in-
hibition of TLE1 corepressor complex dis-
missal.
pressing CaMKII. Addition of the pharmacological in- to be markedly inhibited (Figure 5A). To investigate
whether PARP-1 might itself be a substrate for CaMK-hibitor of PARP-1 (3AB) blocked these events, as did
addition of CaMK inhibitor, KN-62 (Figure 4D and data dependent phosphorylation, we evaluated the phos-
phorylation and auto-poly(ADP-ribosyl)ation of PARP-1not shown). Similarly, addition of KN-62 or 3AB inhibited
dismissal of the TLE1 complex from the MASH1 pro- usingT3-1 cells, which expressedhigh levels of CaMKII,
by transfecting HA-PARP-1 expression vectors, treatingmoter, as assessed by ChIP assay (Figures 3E and 4E).
Together with previous reports that protein-protein in- with KN-62 for 12 hr, immunoprecipitating with HA IgG,
and immunoblotting with PARP IgG, PAR IgG, orteractions were attenuated by poly(ADP-ribosyl)ation,
our data imply that PDGF-induced poly(ADP-ribosyl)a- phosphoserine IgG. As seen in Figure 5B, addition of
KN-62 to inhibit CaMK activity caused a marked inhibi-tion results in dismissal of the TLE1 complex from the
MASH1 promoter of differentiating NSCs after PDGF tion of both phosphorylation of PARP-1, as well as its
auto-poly(ADP-ribosyl)ation. Consistent with this, it hastreatment. Thus, while our data indicated a promoter
specificity to CaMKII-dependent PARP-1 activation, been reported that PARP-1 activity can be regulated
by phosphorylation of serine residue(s) during Xenopusthe biochemical data do not preclude signal-induced
enzymatic function of PARP-1 off the DNA. This would oocyte maturation (Aoufouchi and Shall, 1997). There-
fore, PARP-1 activation is consistent with the posttrans-be quite analogous to promoter-specific effects of li-
gands on nuclear receptors, but with cofactor exchange lational modification by CaMKII and provides a molecu-
lar mechanism for derepression events.also occurring off the DNA as a component of transre-
pression events (reviewed in Glass and Rosenfeld In order to extend these results, we utilized a mutant-
type (E988A) PARP-1 that has been established to lack[2000]).
We next inquired whether poly(ADP-ribosyl)ation ac- ADP-ribose polymerase activity (Marsischky et al.,
1995). NSCs overexpressing either wild- or mutant-typetivity of PARP-1 is actually required for MASH1 activa-
tion in PDGF-treated, differentiating NSCs. When rat PARP-1/EGFPweremaintained in PDGF containingme-
dia for 24 hr. In the case of wild-type PARP-1, MASH1NSCswere maintained in PDGF for 24 hr in the presence
of 3AB, PDGF-induced MASH1 expression was found expression was easily detected in the differentiating
Cell
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Figure 5. Enzymatic Activation of PARP-1 in Derepression Events
(A) Inhibition of PARP-1 activity blocked PDGF-dependent induction of MASH1 transcription in 100 M 3AB-treated NSCs.
(B) CaMKII-dependent phosphorylation of PARP-1 activates PARP-1 enzymatic activity in T3-1 cells.
(C and D) Inactivation of activity of PARP-1 or PARP-1 shRNA suppress MASH1 expression in the differentiating rat NSCs.
(E) Mutant-type (E988) PARP-1 blocks dismissal of the TLE1 corepressor complex and MASH1 gene activation. A two-step ChIP analysis
using anti-Flag antibody in the first round and the second round of ChIP was performed with the indicated IgGs.
NSCsby immunostaining (Figure 5C),with 80%ofEGFP- Regulated Switch of HES1 Function from Gene
Repression to Gene Activationpositive cells exhibiting high levels of MASH1 expres-
sion (Figure 5D). However, when NSCs overexpressed Because HES1 remains bound to the MASH1 promoter
in differentiating NSCs by ChIP analysis (Figures 3A andthe mutant-type (E988) PARP-1 instead, they no longer
responded to the PDGF treatment with decreased 3B), we considered the possibility that HES1might func-
tion as a required activator ofMASH1 gene transcriptionMASH1 expression in most of the EGFP-positive cells
(Figures 5C and 5D). To eliminate the possibility that in differentiating NSCs. To test this hypothesis, we mi-
croinjected siRNA against HES1 transcripts into theoverexpression of wild- or mutant-type PARP-1 has
toxic effects of cell viability, we applied shRNA approach NSCs with TRITC-conjugated dextran together, main-
taining cells in PDGF-containing media for 48 hr. Immu-to knock down PARP-1 transcripts in the differentiating
NSCs. In concert with actions of mutant PARP-1, we nostaining the cells with specific anti-MASH1 antibody
revealed that MASH1 expression markedly decreasedfailed to detect MASH1 expression in most of shPARP-1
transfected NSCs upon PDGF treatment for 48 hr (Fig- in the HES1 siRNA-injected NSCs, but not in control
siRNA-injected NSCs (Figure 6A). MASH1 expressionures 5C and 5D). To independently test whether poly-
(ADP-ribosyl)ation activity of PARP-1 is required for levels were now similar to those observed in the FGF2-
treated proliferating NSCs. These results indicate thatMASH1 activation, two-step ChIP analysis was per-
formedafter transfectionofFlag-taggedwild- ormutant- HES1 is required forMASH1 activation in differentiating
cortical progenitor cells.type (E988A) PARP-1 into NSCs following PDGF treat-
ment for 48 hr. In contrast to events with wild-type We used an independent assay to confirm that HES1
acts as an activator during NSC differentiation by per-PARP-1, we failed to detect replacement of corepressor
by coactivator in mutant-type PARP-1-overexpressing forming shRNA experiments, assessing expression of a
reporter under control of the 1.5 kbMASH1promoter. NoNSCs (Figure 5E). Together, these data suggest that the
poly(ADP-ribosyl)ation activity of PARP-1 is required for MASH1 promoter activation was observed after PDGF
treatment (48 hr) in HES1 shRNA-transfected cells (Fig-dismissal of the TLE1 complex and for MASH1 gene
activation in differentiating NSCs. ure 6B). To exclude the possibility that HES1 had lost
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its DNA binding activity upon PDGF treatment, we com- crease occurring with HES1 mutated in the serine resi-
due in the so-called “orange” domain (S126A) (Figurepared the level of HES1-specific class C DNA binding
activity present in nuclear extracts from proliferating or 6H). These results were consistent with the possibility
that phosphorylation of specific sites on HES1 might bedifferentiating NSCs after PDGF treatment for 12 and
24 hr. We observed that the level of endogenous binding required for MASH1 activation. In contrast to wild-type
HES1, the mutant-type (S126A) HES1 protein showed aactivity did not decrease after 24 hr of PDGF treatment;
indeed, it actually increased (Figure 6C). Western blot significant decrease in levels of detected phosphoryla-
tion, even in KCl (50 mM)-treated cells (Figure 6I). Whileanalysis of the nuclear extracts indicated no striking
decrease in the levels of expression of HES1 protein HES1 can be phosphorylated in a CaMKII-dependent
fashion in the tested cell types, it undoubtedly alsobetween proliferating and differentiating NSCs after 24
hr of PDGF treatment (Figure 6C). serves as a substrate for other protein kinases, perhaps
in a cell type-specific fashion. DNA binding activity of
purified, bacterially expressed GSTwild- or mutant-typeCaMKII-Dependent Phosphorylation of HES1
(S126A) HES1 protein was not altered based on electro-Promotes Activation Events
phoretic mobility gel shift assays with a synthetic dou-Two-step chromatin immunoprecipitation analyses were
ble-stranded oligonucleotide corresponding to theperformed in PDGF-treated NSCs to confirm that HES1
HES1-specific class C DNA site using extracts from ratwas present on the sameMASH1 promoters as PARP-1,
NSCs (see Supplemental Figure S6 on the Cell website).CBP, and CaMKII, as well as other coactivator com-
In accord with these observations, HES1 is expressedplexes, confirming that PARP-1 was bound to activated
strongly not only in the proliferating NSCs, but also inpromoters on which HES1 was present (Figure 6D). We
most of the MASH1-positive cells following 24 hr oftherefore further investigated the underlying mecha-
PDGF treatment (Figure 6J). Multipotent FGF2-treatednisms of the “switch” in HES1 function from repression
proliferating cortical progenitor cells failed to exhibitto activation. First, we explored regulated interactions
MASH1 expression.of HES1 with coactivators and then investigated the
To test the functional effects of these putative phos-potential role of the enzymatic activity of CaMKII. To con-
phorylation sites, we microinjected NSCs with rat-spe-firm potential interactions between HES1 with CBP-con-
cific siRNA against HES1 and with wild- or mutant-typetainingcoactivatorcomplexes, coimmunoprecipitation ex-
humanHES1expression vectorswith TRITC-conjugatedperiments were performed, revealing a strong interaction
dextran together. While wild-type human HES1 couldbetween HES1 and CBP in cotransfection experiments
rescue MASH1 expression in the differentiating NSCs,(Figure 6E). KN-62 treatment caused a loss of HES1/
HES1 proteins harboring mutations in several CaMKCBP interactions, suggesting that CaMKII-dependent
phosphorylation sites, particularly the S126A mutation,phosphorylation may be necessary for HES1/CBP inter-
could no longer rescue MASH1 expression (Figure 7A).actions. Consistent with a potential activation role for
Taken together, our data support the hypothesis thatHES1, transient transfection of a HES1 expression vec-
phosphorylation of HES1 by CaMKII is linked to recruit-tor can actually activate MASH1 promoter-driven re-
ment of coactivator complexes, including CBP, whichporter in AtT20 cells, which exhibit oscillations in Ca2
functionally converts HES1 to a DNA binding transcrip-flux, and this HES1-dependent activation of MASH1 is
tional activator required to induce MASH1 transcriptionblocked by KN-62 treatment (Figure 6F).
in differentiating NSCs.Because of the requirement for CaMKII in activation
events and the recruitment of CaMKII to the MASH1
Discussionpromoter, and previous studies documenting that the
calcium signaling-induced modifications of transcrip-
Defining the coordinated molecular strategies that un-tion factors can involve actions of CaMK (Shaywitz and
derlie the transition fromamultipotent state to differenti-Greenberg, 1999), we investigated the potential role of
ation along specific lineage pathways, such as the pro-CaMK-dependent phosphorylation sites (R/KXXS/T).
gression from a neural stem cell state to developmentWe tested the hypothesis that HES1 is phosphorylated
along a neuronal pathway, remains a central issue inby CaMKIIduring NSCdifferentiation. HA-taggedHES1
development. Here, we have reported a pathway thatprotein was overexpressed in T3-1 cells in the presence
underlies a component of these switching events in neu-or absence of KN-62 together with KCl, and Western
ronal differentiation, based on regulation by two func-blot analysis was performed. After immunoprecipitation
tionally distinct classes of bHLH transcription factors.of nuclear extracts with anti-HA antibody, phosphoryla-
tion levels of HES1 were analyzed using anti-phospho-
serine antibodies (Figure 6G). Significant phosphoryla- PARP-1 Is a Component of the TLE1 Corepressor
Complex Mediating Derepression Eventstion of wild-type HES1 was detected and a marked
decrease in serine phosphorylation was observed in the during Neural Stem Cell Differentiation
We find that HES1-dependent repression of MASH1 ispresence of KN-62. To investigate whether these con-
sensus CaMK phosphorylation sites might function in dependent upon the actions of the TLE1 corepressor
complex. We have not only provided additional insightscoactivation, we performed coimmunoprecipitation analy-
sis with CBP and wild- or mutant-type on HES1 proteins into the molecular mechanisms of TLE1-mediated re-
pression but also uncovered the molecular mechanismharboring individual mutations of each potential phos-
phorylation site. We observed a significantly decreased of the switch to activation function. The composition of
this TLE1 complex is distinct from those of other re-affinity between CBP and HES1mutated serine residues
in the bHLH domain (S70A) with the most dramatic de- ported corepressor complexes such as N-CoR/SMRT
Cell
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and CtBP (reviewed in Jepsen and Rosenfeld [2002]; Dual Roles of HES1 in Neural Stem
Cell DevelopmentYoon et al. [2003]; Shi et al. [2003]). Interestingly, roles
Our data also indicate that, in addition to Ca2-CaMKII-for transcriptional regulation and chromatin remodeling
dependent dissociation of the TLE1 corepressor fromactivities have been described for most of the compo-
HES1, a covalent modification of HES1 itself is requirednents of the TLE1 complex that we have identified (Brou
to permit activation of MASH1. Thus, activation ofet al., 1993; Adachi et al., 1991; Inouye and Seto, 1994;
MASH1 is linked to sequential CaMKII-dependent acti-Yang et al., 1994; Tsai et al., 2000; Okuwaki et al., 2001;
vation of PARP-1 enzymatic activity, which was pre-Roger et al., 2002; Gabellini et al., 2002; Sewer and
viously inhibited in the TLE1 holocorepressor complex,Waterman, 2002), but we found that no component is
permitting dismissal of the TLE1 complex, derepressionalone indispensable for at least some level of TLE1-
and phosphorylation of HES1, and recruitment of spe-mediated repression.
cific coactivators and thus causing and maintaining de-Consistent with the observation that the enzymatic
repression of genes mediating neuronal differentiation.activity of PARP-1 is not required for HES1-mediated
The actions of PARP-1 in the TLE1-mediated events areMASH1 repression, our data favors a model predicting
thus analogous to the effects of covalent modificationsthat in the TLE1 holorepressor complex the enzymatic
by phosphorylation and acetylation, as mediators ofactivity of PARP-1 is inhibited. Exposure to a signal
switches from repressor to activator function (Mannervikinducing neuronal differentiation causes activation of
et al., 1999).CaMKII, which is proven to be required for activation
While HES1 is recognized to regulate tissue morpho-of neurogenic genes. Once sufficient levels of CaMKII
genesis by maintaining undifferentiated cells and pre-are achieved (5–7 hr), it will, directly or indirectly, medi-
venting differentiation (Ishibashi et al., 1995; Ohtsuka etate phosphorylation and activation of PARP-1, which
al., 2001), continued occupancy of theMASH1 promoterthen catalyzes poly(ADP-ribosyl)ation of TLE1 and most
by HES1 in the differentiating neural stem cells has sur-of the other components to the corepressor complex.
prisingly proven to be required to initiateMASH1 activa-This is consistent with the observation that calcium sig-
tion events. Indeed, previous, seemingly contradictorynaling evoked by extrinsic and intrinsic cues can induce
reports of transient transfection assays in which HES1auto-poly(ADP-ribosyl)ation of PARP-1 (Homburg et al.,
can inhibit acid -glucosidase genes in HepG2 cells but
2000; Kun et al., 2004); however, CaMKII may also be
cause activation in fibroblasts (Yan et al., 2001, 2002)
activated in a calcium-independent fashion. This cova- are likely to be explained by our findings of signal-
lent modification is suggested to result in their dismissal dependent HES1 switching events.
from the biochemical complex and derepression of the This cortical progenitor culture system has permitted
MASH1 gene. The role of PARP-1 in derepression of identification of a regulatory pathway that may be, at
MASH1 and its retention on the activated MASH1 pro- least in part, partially compensated in vivo because
moter is quite consistent with reports that poly(ADP- many nestin-positive neural stem cells in the subventri-
ribosyl)ation of chromatin-associated proteins induce cular zone proliferatewithout losing themultipotentiality
major changes in chromosomal architecture (reviewed to differentiate into neurons in HES1 mutant or even
in D’Amours et al. [1999]; Kraus and Lis [2003]). How- HES1/HES5 double mutant mice (Ishibashi et al., 1995;
ever, in the case of MASH1, we have found that dere- Ohtsuka et al., 2001). We suggest that there may be
pression alone is insufficient for induction. This is in additional HES1-like repressors or unidentified protein
accordwith the findings for other regulated transcription partners, including HERP and other E box binding pro-
factors. For example, the loss of the N-CoR corepressor teins, that are also potentially involved in MASH1 gene
is not alone sufficient to activate most AP-1-regulated activation. The identification of this unexpected mecha-
genes, and only in a subset of RAR target genes does nism of HES1 action in cortical progenitor cell cultures
derepression result in a signal-independent “default” suggest that, in this system, the other molecules that
could assume a similar function were either not ex-activation of gene targets (Ogawa et al., 2004).
Figure 6. Conversion of the HES1 Repressor to a Required Activator during Neural Stem Cell Differentiation
(A) Microinjection of HES1 siRNA suppresses MASH1 expression in the differentiating rat NSCs. Photomicrographs of MASH1 expression in
the HES1 siRNA microinjected NSCs are shown on the right, while fold increase of MASH1 expression is shown on the left as assessed by
the NIH Image Program.
(B) Knockdown of HES1 shRNA suppresses MASH1 promoter reporter activity.
(C) HES1 DNA binding activity in nuclear extracts from proliferating or differentiating rat NSCs treated with PDGF for 12 hr and 24 hr.
(D) Two-step ChIP analysis of HES1/coactivator complex; after a first round of ChIP using anti-HES1 IgG in differentiating NSCs, a second
round of ChIP was performed with the indicated antibodies.
(E) HES1 interactions with the CBP coactivator complex in vivo. AlphaT3-1 cells coexpressing HES1 and CBP were cultured in the absence
or presence of 30 M KN-62 for 12 hr. Coimmunoprecipitation assays were performed with anti-CBP or anti-HES1 IgG.
(F) Expression of HES1 in AtT20 cells activates the MASH1 promoter reporter activity in response to calcium signaling.
(G) HES1 can be phosphorylated by CaMKII in vivo.
(H) Schematic representation of murine HES1 showing the location of consensus CaMKII phosphorylation sites, each of which was mutated
as diagrammed (right panel). After cotransfection of mutant HES1 and CBP into T3-1 cells, coimmunoprecipitation assays were performed.
(I) Effects of KCl (50 mM)  KN-62 (30 M) on phosphorylation of HA-HES1 (S126A) in an experiment performed simultaneously with that
shown in (G).
(J) Colocalization of HES1 and MASH1 in the differentiating rat neural stem cells. Double immunostaining was performed with anti-HES1
(green) and anti-MASH1 (red) antibodies in the proliferating or differentiating rat NSCs.
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Figure 7. Dismissal of TLE1 Complex and Recruitment of CBP Complex for MASH1 Activation during Neural Differentiation
(A) The microinjected rat NSCs were maintained in PDGF-containing medium for 48 hr. Relative expression of MASH1 is shown on left as
assessed by the NIH Image Program, while photomcirographs of the MASH1 expression in HES1 (S126A) experiment are shown on the right.
(B) Model of the CaMKII/TLE1/PARP-1/HES1 pathway action in repressor switching events required for neuronal differentiation (see Dis-
cussion).
pressed or required. Our finding of a requirement of ation, such as PDGF in neural stem cells, act to induce
theCaMKII isoform,which, in turn, is required for HES1-HES1 in activation of neurogenic genes is consistent
with suggestions that HES1 might promote differentia- mediated MASH1 activation (Figure 7B). The temporal
aspects of CaMKII induction appear to account for thetion, in addition to its role in maintenance of the undiffer-
entiated state, atmultiple steps of neural stemcell devel- delay in derepression and activation of MASH1 expres-
sion following critical PDGF signaling. CaMKII-inducedopment.
phosphorylation of a specific serine residue in the or-
ange domain of HES1 permits it to recruit coactivators,Model of PARP-1-Mediated Exchange
including CBP, and has proven to be required for activa-and HES1 Activation
tion of the MASH1 (Figure 7B). The conserved relation-In summary, we suggest a pathway in which a PARP-1-
ship of the HES1 orange domain with the HLH domaincontaining TLE1 complex is recruited by the Notch-
raises the possibility of an additional role in protein inter-induced bHLH factor, HES1, initially mediating repres-
actions that include dimerization (Davis and Turner,sion ofMASH1 in the proliferating neural stem cells. Our
data suggest that signals that induce neuronal differenti- 2001).
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Gel-Filtration ChromatographyIn a sense, the observation that a component of the
Gel-filtration chromatography was performed with a Superose 6 HRTLE1-mediated repression complex, PARP-1, is also
10/30 column (Amersham).required for derepression events and maintenance of
activation parallels the requirement of TBL1/TBLR1 Immunoprecipitation and Chromatin Immunoprecipitation
complex for ligand-dependent exchange ofN-CoRcore- Immunoprecipitation was performed by standard methods (see the
pressor complexes for coactivators in the switch of nu- Supplemental Data online). Chromatin immunoprecipitation was
performed on neural stem cells largely as described (Jepsen et al.,clear receptor function from repression to activation
2000; Shang et al., 2000).(Perissi et al., 2004). TBLR1 is required for recruitment of
the ubiquitylation/19S proteosome complex to prevent
Poly(ADP-ribosyl)ation Assay
N-CoR/SMRT-dependent maintenance of a repression The nuclear extract was immunoprecipitated using a variety of anti-
checkpoint. We suggest that PARP-1 may achieve the bodies under highly stringent conditions (420 mM NaCl). Poly(ADP-
same effects by a distinct modification strategy and ribosyl)ated proteins were detected in Western blots with anti-PAR
monoclonal antibody (10H, Alexis Biochemical), which is known toserves as a regulated sensor of neuron-inducing signals
be specific and reliable for poly(ADP-ribose) detection.based on the actions of CaMKII induced by the initial
stimulus to neuronal differentiation. Therefore, we are
Single-Cell Nuclear Microinjection Assays
tempted to speculate that PARP-1 and TBLR1 may be Microinjection assayswere carried out as previously described (Jep-
critical for the exchange events required to overcome sen et al., 2000). Results are mean  SEM 	100 cells injected for
the repression checkpoint for TLE- and N-CoR-regu- each data point. See the Supplemental Data for procedures and
siRNAs design.lated repressors, respectively.
The dual functions of PARP-1 and HES1 in the pro-
Immunohistochemistrygression of neural stem cells along a neuronal pathway
Immunohistochemistry was performed largely as previously de-indicate that while the initial Notch signal causes repres-
scribed (Jepsen et al., 2000).
sion of neurogenic genes by induction of HES1, it simul-
taneously arms the response to subsequent Ca2- Electrophoretic Mobility-Shift Assay
CaMKII signals that permit MASH1 gene activation For gel-shift assays with nuclear extracts from rat neural stem cells
or purified GST-HES1 protein, we followed protocol as previouslyevents. Our data illustrate how a single signaling path-
described (Stro¨m et al., 1997). See the Supplemental Data for oligo-way can mediate a sequential, two-step derepression/
nucleotide sequences.activation process required for development in gene
activation. Induction of a Ca2/CaMKII-dependent pro- Plasmid-Based RNA Interference (shRNA)
gram initiates both PARP-1 activation, which is required Plasmid-based RNA interference experiments were carried out as
for dismissal of the TLE1 corepressor complex, and a previously described using pSuper vector (Brummelkamp et al.,
2002) or modified pSuper vector with PGK promoter-EGFP. See thesecond event, covalent modification of HES1, which is
Supplemental Data for shRNAs design.required for target gene activation. The requirement for
both a derepression and independently mediated acti-
RNA Isolation and RT-PCR Analysisvation event is likely to be prototypic of many similar RT-PCR products were prepared as described in the Supplemental
functions of PARP-1 factors in development. The se- Data and were analyzed by agarose gel electrophoresis.
quential calcium-regulated PARP-1-dependent switch
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